Europlasma S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 15.41 million compared to EUR 14.52 million a year ago. Net loss was EUR 14.74 million compared to EUR 15.92 million a year ago.

Basic loss per share from continuing operations was EUR 1,050 compared to EUR 15 a year ago. Diluted loss per share from continuing operations was EUR 35 compared to EUR 15 a year ago.